Review



ritlecitinib standard substance  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress ritlecitinib standard substance
    Structure of the irreversible Janus kinase 3 and tyrosine kinase inhibitor, <t>ritlecitinib.</t>
    Ritlecitinib Standard Substance, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ritlecitinib standard substance/product/MedChemExpress
    Average 93 stars, based on 9 article reviews
    ritlecitinib standard substance - by Bioz Stars, 2026-02
    93/100 stars

    Images

    1) Product Images from "The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics"

    Article Title: The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

    Journal: Pharmaceuticals

    doi: 10.3390/ph18010124

    Structure of the irreversible Janus kinase 3 and tyrosine kinase inhibitor, ritlecitinib.
    Figure Legend Snippet: Structure of the irreversible Janus kinase 3 and tyrosine kinase inhibitor, ritlecitinib.

    Techniques Used:

    Summarized system suitability data of the newly developed stability-indicating method  (ritlecitinib  concentration level 10 µg/mL; n = 6).
    Figure Legend Snippet: Summarized system suitability data of the newly developed stability-indicating method (ritlecitinib concentration level 10 µg/mL; n = 6).

    Techniques Used: Concentration Assay

    Representative LC chromatograms of ritlecitinib samples (100 µg/mL): ( a ) control, ( b ) basic, and ( c ) oxidative degradation.
    Figure Legend Snippet: Representative LC chromatograms of ritlecitinib samples (100 µg/mL): ( a ) control, ( b ) basic, and ( c ) oxidative degradation.

    Techniques Used: Control

    Summarized forced degradation study data.
    Figure Legend Snippet: Summarized forced degradation study data.

    Techniques Used:

    UHPLC-ESI-QQQ data of  ritlecitinib  and its degradation products.
    Figure Legend Snippet: UHPLC-ESI-QQQ data of ritlecitinib and its degradation products.

    Techniques Used:

    Mass spectra data of ritlecitinib. ( a ) Full scan ESI-MS spectrum, showing the protonated molecular ion [M+H] + at m / z 286. ( b ) Product ion ESI-MS/MS spectrum of the protonated molecular ion [M+H] + ( m / z 286), collision energy of 20 V (insert: proposed fragmentation pattern).
    Figure Legend Snippet: Mass spectra data of ritlecitinib. ( a ) Full scan ESI-MS spectrum, showing the protonated molecular ion [M+H] + at m / z 286. ( b ) Product ion ESI-MS/MS spectrum of the protonated molecular ion [M+H] + ( m / z 286), collision energy of 20 V (insert: proposed fragmentation pattern).

    Techniques Used: Tandem Mass Spectroscopy

    The MoGAPI score of ritlecitinib forced degradation protocol.
    Figure Legend Snippet: The MoGAPI score of ritlecitinib forced degradation protocol.

    Techniques Used:

    The ComplexGAPI score of ritlecitinib forced degradation protocol.
    Figure Legend Snippet: The ComplexGAPI score of ritlecitinib forced degradation protocol.

    Techniques Used:

    The AGREE score of ritlecitinib forced degradation protocol.
    Figure Legend Snippet: The AGREE score of ritlecitinib forced degradation protocol.

    Techniques Used:

    The AGREEprep score of ritlecitinib forced degradation protocol.
    Figure Legend Snippet: The AGREEprep score of ritlecitinib forced degradation protocol.

    Techniques Used:

    The BAGI score of ritlecitinib forced degradation protocol.
    Figure Legend Snippet: The BAGI score of ritlecitinib forced degradation protocol.

    Techniques Used:



    Similar Products

    93
    MedChemExpress ritlecitinib standard substance
    Structure of the irreversible Janus kinase 3 and tyrosine kinase inhibitor, <t>ritlecitinib.</t>
    Ritlecitinib Standard Substance, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ritlecitinib standard substance/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    ritlecitinib standard substance - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    Image Search Results


    Structure of the irreversible Janus kinase 3 and tyrosine kinase inhibitor, ritlecitinib.

    Journal: Pharmaceuticals

    Article Title: The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

    doi: 10.3390/ph18010124

    Figure Lengend Snippet: Structure of the irreversible Janus kinase 3 and tyrosine kinase inhibitor, ritlecitinib.

    Article Snippet: The ritlecitinib standard substance (assigned purity 99.98%) was purchased from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques:

    Summarized system suitability data of the newly developed stability-indicating method  (ritlecitinib  concentration level 10 µg/mL; n = 6).

    Journal: Pharmaceuticals

    Article Title: The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

    doi: 10.3390/ph18010124

    Figure Lengend Snippet: Summarized system suitability data of the newly developed stability-indicating method (ritlecitinib concentration level 10 µg/mL; n = 6).

    Article Snippet: The ritlecitinib standard substance (assigned purity 99.98%) was purchased from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: Concentration Assay

    Representative LC chromatograms of ritlecitinib samples (100 µg/mL): ( a ) control, ( b ) basic, and ( c ) oxidative degradation.

    Journal: Pharmaceuticals

    Article Title: The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

    doi: 10.3390/ph18010124

    Figure Lengend Snippet: Representative LC chromatograms of ritlecitinib samples (100 µg/mL): ( a ) control, ( b ) basic, and ( c ) oxidative degradation.

    Article Snippet: The ritlecitinib standard substance (assigned purity 99.98%) was purchased from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: Control

    Summarized forced degradation study data.

    Journal: Pharmaceuticals

    Article Title: The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

    doi: 10.3390/ph18010124

    Figure Lengend Snippet: Summarized forced degradation study data.

    Article Snippet: The ritlecitinib standard substance (assigned purity 99.98%) was purchased from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques:

    UHPLC-ESI-QQQ data of  ritlecitinib  and its degradation products.

    Journal: Pharmaceuticals

    Article Title: The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

    doi: 10.3390/ph18010124

    Figure Lengend Snippet: UHPLC-ESI-QQQ data of ritlecitinib and its degradation products.

    Article Snippet: The ritlecitinib standard substance (assigned purity 99.98%) was purchased from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques:

    Mass spectra data of ritlecitinib. ( a ) Full scan ESI-MS spectrum, showing the protonated molecular ion [M+H] + at m / z 286. ( b ) Product ion ESI-MS/MS spectrum of the protonated molecular ion [M+H] + ( m / z 286), collision energy of 20 V (insert: proposed fragmentation pattern).

    Journal: Pharmaceuticals

    Article Title: The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

    doi: 10.3390/ph18010124

    Figure Lengend Snippet: Mass spectra data of ritlecitinib. ( a ) Full scan ESI-MS spectrum, showing the protonated molecular ion [M+H] + at m / z 286. ( b ) Product ion ESI-MS/MS spectrum of the protonated molecular ion [M+H] + ( m / z 286), collision energy of 20 V (insert: proposed fragmentation pattern).

    Article Snippet: The ritlecitinib standard substance (assigned purity 99.98%) was purchased from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: Tandem Mass Spectroscopy

    The MoGAPI score of ritlecitinib forced degradation protocol.

    Journal: Pharmaceuticals

    Article Title: The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

    doi: 10.3390/ph18010124

    Figure Lengend Snippet: The MoGAPI score of ritlecitinib forced degradation protocol.

    Article Snippet: The ritlecitinib standard substance (assigned purity 99.98%) was purchased from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques:

    The ComplexGAPI score of ritlecitinib forced degradation protocol.

    Journal: Pharmaceuticals

    Article Title: The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

    doi: 10.3390/ph18010124

    Figure Lengend Snippet: The ComplexGAPI score of ritlecitinib forced degradation protocol.

    Article Snippet: The ritlecitinib standard substance (assigned purity 99.98%) was purchased from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques:

    The AGREE score of ritlecitinib forced degradation protocol.

    Journal: Pharmaceuticals

    Article Title: The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

    doi: 10.3390/ph18010124

    Figure Lengend Snippet: The AGREE score of ritlecitinib forced degradation protocol.

    Article Snippet: The ritlecitinib standard substance (assigned purity 99.98%) was purchased from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques:

    The AGREEprep score of ritlecitinib forced degradation protocol.

    Journal: Pharmaceuticals

    Article Title: The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

    doi: 10.3390/ph18010124

    Figure Lengend Snippet: The AGREEprep score of ritlecitinib forced degradation protocol.

    Article Snippet: The ritlecitinib standard substance (assigned purity 99.98%) was purchased from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques:

    The BAGI score of ritlecitinib forced degradation protocol.

    Journal: Pharmaceuticals

    Article Title: The Stability-Indicating Ultra High-Performance Liquid Chromatography with Diode Array Detector and Tandem Mass Spectrometry Method Applied for the Forced Degradation Study of Ritlecitinib: An Appraisal of Green and Blue Metrics

    doi: 10.3390/ph18010124

    Figure Lengend Snippet: The BAGI score of ritlecitinib forced degradation protocol.

    Article Snippet: The ritlecitinib standard substance (assigned purity 99.98%) was purchased from MedChemExpress (Monmouth Junction, NJ, USA).

    Techniques: